(Asp-Ser-Ser) 6

(Asp-Ser-Ser) 6 ((DSS) 6) is an artificially designed bone-targeting peptide. (Asp-Ser-Ser) 6 is used as a ligand to modify apoptotic extracellular vesicles (ApoEVs) in order to enhance the bone targeting and efficacy of ApoEVs in the treatment of osteoporosis. (Asp-Ser-Ser) 6 can be used for research on osteoporosis[1].

Product Specifications

CAS Number

[929906-72-9]

Product Name Alternative

(DSS) 6

UNSPSC

12352209

Target

Others

Related Pathways

Others

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease

Smiles

O=C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@@H](CC(O)=O)C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@@H](CC(O)=O)C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@@H](CC(O)=O)C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@@H](CC(O)=O)C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@@H](CC(O)=O)C(N[C@@H](CO)C(N[C@@H](CO)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC(O)=O)N

Molecular Formula

C60H92N18O43

Molecular Weight

1753.47

References & Citations

[1]Gui L, et al. Bone-Targeting Peptide and RNF146 Modified Apoptotic Extracellular Vesicles Alleviate Osteoporosis. Int J Nanomedicine. 2024 Jan 17;19:471-488.